EUVIMEDEUVIMED entdecken
Crossref

Exploring new frontiers: Effects of psychedelics on neurotransmitter‐regulated glucagon release in pancreatic islets

Mehmet Bostancıklıoğlu iD

Diabetes, Obesity and Metabolism · 2024

DOI: 10.1111/dom.15411 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2024. Verfasst von Mehmet Bostancıklıoğlu. Beteiligte Einrichtung: Institute of Experimental and Clinical Research, Pole of Endocrinology, Diabetes and Nutrition, Université Catholique de Louvain, Brussels, Belgium. Hauptthemen laut MEDLINE: Hallucinogens, Islets of Langerhans. Die Arbeit nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HallucinogensIslets of LangerhansHumansGlucagonInsulinNeurotransmitter AgentsGlucose

Substanzen

GlucagonHallucinogensInsulinNeurotransmitter AgentsGlucose

Autor:innen und Institutionen

  • Institute of Experimental and Clinical Research, Pole of Endocrinology, Diabetes and Nutrition, Université Catholique de Louvain, Brussels, Belgium.

ORCID-Profile: Mehmet Bostancıklıoğlu

Zitieren

APA

Bostancıklıoğlu, M. (2024). Exploring new frontiers: Effects of psychedelics on neurotransmitter‐regulated glucagon release in pancreatic islets. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15411

Vancouver

Bostancıklıoğlu M. Exploring new frontiers: Effects of psychedelics on neurotransmitter‐regulated glucagon release in pancreatic islets. Diabetes, Obesity and Metabolism. 2024. doi:10.1111/dom.15411

BibTeX
@article{Bostancklolu2024,
  author = {Bostancıklıoğlu, Mehmet},
  title = {Exploring new frontiers: Effects of psychedelics on neurotransmitter‐regulated glucagon release in pancreatic islets},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  doi = {10.1111/dom.15411}
}
Kostenlos starten →